Immunoblotting results from both AD mice samples demonstrated that PRO-Br specifically reduced the expression of sarkosyl-insoluble phospho-tau variants in a dose-dependent manner (Figures 3A–D). This evidence concerns the gene MAPT and Alzheimer disease.